Walleye Capital LLC Biomarin Pharmaceutical Inc Put Options Transaction History

Walleye Capital LLC

  • $46.2 Billion
  • Q3 2024

Put Options

12 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$69.02 - $93.84 $227,766 - $309,672
3,300 Added 16.02%
23,900 $1.68 Million
Q2 2024

Aug 14, 2024
BUY
$74.43 - $92.22 $811,287 - $1.01 Million
10,900 Added 112.37%
20,600 $1.7 Million
Q1 2024

May 15, 2024
SELL
$83.81 - $99.0 $1.14 Million - $1.35 Million
-13,600 Reduced 58.37%
9,700 $847,000
Q4 2023

Feb 14, 2024
BUY
$76.22 - $98.51 $297,258 - $384,189
3,900 Added 20.1%
23,300 $2.25 Million
Q3 2023

Nov 14, 2023
BUY
$85.07 - $94.48 $910,248 - $1.01 Million
10,700 Added 122.99%
19,400 $1.72 Million
Q2 2023

Aug 14, 2023
SELL
$86.68 - $100.3 $927,476 - $1.07 Million
-10,700 Reduced 55.15%
8,700 $754,000
Q1 2023

May 15, 2023
BUY
$87.74 - $117.27 $1.33 Million - $1.78 Million
15,200 Added 361.9%
19,400 $1.89 Million
Q4 2022

Feb 14, 2023
BUY
$80.93 - $108.63 $339,906 - $456,246
4,200 New
4,200 $434,000
Q1 2020

May 15, 2020
SELL
$71.37 - $96.85 $35,685 - $48,425
-500 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$64.27 - $86.37 $964,049 - $1.3 Million
-15,000 Reduced 96.77%
500 $42,000
Q3 2019

Nov 14, 2019
BUY
$67.4 - $85.11 $714,440 - $902,166
10,600 Added 216.33%
15,500 $1.05 Million
Q1 2019

May 15, 2019
BUY
$84.2 - $98.62 $412,580 - $483,238
4,900 New
4,900 $435,000

Others Institutions Holding BMRN

# of Institutions
638
Shares Held
178M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.5B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email